Search research articles
Contact Us
Filters
Showing results (41-50 of 54) with videos related to
Page
of 6
Sort By:
Virology Journal
|
December 4, 2009
Amphipathic DNA polymers exhibit antiviral activity against systemic murine Cytomegalovirus infection
Rhonda D Cardin, Fernando J Bravo, Andrea P Sewell, et al.
Antiviral Therapy
|
February 5, 2008
Amphipathic DNA polymers are candidate vaginal microbicides and block herpes simplex virus binding, entry and viral gene expression
Esmeralda M Guzman, Natalia Cheshenko, Vikas Shende, et al.
Antimicrobial Agents and Chemotherapy
|
February 24, 2006
Potent antiscrapie activities of degenerate phosphorothioate oligonucleotides
David A Kocisko, Andrew Vaillant, Kil Sun Lee, et al.
Antiviral Research
|
November 12, 2017
Activity of nucleic acid polymers in rodent models of HBV infection
Katrin Schöneweis, Neil Motter, Pia L Roppert, et al.
Gastroenterology
|
March 10, 2020
Safety and Efficacy of 48 Weeks REP 2139 or REP 2165, Tenofovir Disoproxil, and Pegylated Interferon Alfa-2a in Patients With Chronic HBV Infection Naïve to Nucleos(t)ide Therapy
Michel Bazinet, Victor Pântea, Gheorghe Placinta, et al.
Journal of Viral Hepatitis
|
February 8, 2021
Benefit of transaminase elevations in establishing functional cure of HBV infection during nap-based combination therapy
Michel Bazinet, Victor Pântea, Gheorghe Placinta, et al.
Scientific Reports
|
May 14, 2020
Modelling hepatitis D virus RNA and HBsAg dynamics during nucleic acid polymer monotherapy suggest rapid turnover of HBsAg
Louis Shekhtman, Scott J Cotler, Leeor Hershkovich, et al.
Gastroenterology
|
April 28, 2009
Amphipathic DNA polymers inhibit hepatitis C virus infection by blocking viral entry
Takuya Matsumura, Zongyi Hu, Takanobu Kato, et al.
Plos One
|
November 13, 2015
Therapeutic Antiviral Effect of the Nucleic Acid Polymer REP 2055 against Persistent Duck Hepatitis B Virus Infection
Faseeha Noordeen, Catherine A Scougall, Arend Grosse, et al.
Hepatology Communications
|
February 8, 2021
Persistent Control of Hepatitis B Virus and Hepatitis Delta Virus Infection Following REP 2139-Ca and Pegylated Interferon Therapy in Chronic Hepatitis B Virus/Hepatitis Delta Virus Coinfection
Michel Bazinet, Victor Pântea, Valentin Cebotarescu, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 54) with videos related to
Sort By:
Page
of 6
Virology Journal
|
December 4, 2009
Amphipathic DNA polymers exhibit antiviral activity against systemic murine Cytomegalovirus infection
Rhonda D Cardin, Fernando J Bravo, Andrea P Sewell, et al.
Antiviral Therapy
|
February 5, 2008
Amphipathic DNA polymers are candidate vaginal microbicides and block herpes simplex virus binding, entry and viral gene expression
Esmeralda M Guzman, Natalia Cheshenko, Vikas Shende, et al.
Antimicrobial Agents and Chemotherapy
|
February 24, 2006
Potent antiscrapie activities of degenerate phosphorothioate oligonucleotides
David A Kocisko, Andrew Vaillant, Kil Sun Lee, et al.
Antiviral Research
|
November 12, 2017
Activity of nucleic acid polymers in rodent models of HBV infection
Katrin Schöneweis, Neil Motter, Pia L Roppert, et al.
Gastroenterology
|
March 10, 2020
Safety and Efficacy of 48 Weeks REP 2139 or REP 2165, Tenofovir Disoproxil, and Pegylated Interferon Alfa-2a in Patients With Chronic HBV Infection Naïve to Nucleos(t)ide Therapy
Michel Bazinet, Victor Pântea, Gheorghe Placinta, et al.
Journal of Viral Hepatitis
|
February 8, 2021
Benefit of transaminase elevations in establishing functional cure of HBV infection during nap-based combination therapy
Michel Bazinet, Victor Pântea, Gheorghe Placinta, et al.
Scientific Reports
|
May 14, 2020
Modelling hepatitis D virus RNA and HBsAg dynamics during nucleic acid polymer monotherapy suggest rapid turnover of HBsAg
Louis Shekhtman, Scott J Cotler, Leeor Hershkovich, et al.
Gastroenterology
|
April 28, 2009
Amphipathic DNA polymers inhibit hepatitis C virus infection by blocking viral entry
Takuya Matsumura, Zongyi Hu, Takanobu Kato, et al.
Plos One
|
November 13, 2015
Therapeutic Antiviral Effect of the Nucleic Acid Polymer REP 2055 against Persistent Duck Hepatitis B Virus Infection
Faseeha Noordeen, Catherine A Scougall, Arend Grosse, et al.
Hepatology Communications
|
February 8, 2021
Persistent Control of Hepatitis B Virus and Hepatitis Delta Virus Infection Following REP 2139-Ca and Pegylated Interferon Therapy in Chronic Hepatitis B Virus/Hepatitis Delta Virus Coinfection
Michel Bazinet, Victor Pântea, Valentin Cebotarescu, et al.
Page
of 6